Kawa Capital initiated a new position in the fourth quarter, buying 160,000 shares of ARE worth $7.93 million.
The ARE stake represents 18.3% of 13F AUM at quarter end.
ARE becomes a significant holding, accounting for nearly one-fifth of reportable AUM after fund downsizing.
On January 21, Kawa Capital Management disclosed a new position in Alexandria Real Estate Equities (NYSE:ARE), acquiring 160,000 shares worth an estimated $7.93 million at quarter-end.
According to its SEC filing dated January 21, Kawa Capital Management, Inc established a new position in Alexandria Real Estate Equities by acquiring 160,000 shares during the fourth quarter. The quarter-end value of the new stake also totaled $7.93 million, reflecting the purchase of new shares.
The ARE stake now represents 18.3% of Kawa Capital Management's reportable U.S. equity assets under management.
Top holdings after the filing:
As of January 20, ARE shares were priced at $57.52, down about 40% over the past year and far underperforming the S&P 500’s roughly 14% gain in the same period.
| Metric | Value |
|---|---|
| Revenue (TTM) | $2.98 billion |
| Net income (TTM) | ($410.94 million) |
| Dividend yield | 8.1% |
| Price (as of January 20) | $57.52 |
Alexandria Real Estate Equities, Inc. specializes in Class A office and laboratory properties tailored for the life sciences and technology sectors, with a significant presence in top U.S. innovation hubs. The company leverages its deep industry relationships and strategic development expertise to attract leading tenants and maintain high occupancy rates. Alexandria's focus on collaborative campus environments and a diversified tenant base supports its competitive positioning and long-term asset value.
Conviction matters most when capital gets scarce, and this portfolio is making that clear. With just four core positions and more than 80% of assets tied up in real estate and materials, the decision to make Alexandria Real Estate Equities nearly a fifth of reportable assets signals a sharp pivot toward income durability and asset quality at a moment of sector stress.
Alexandria’s fundamentals remain sturdier than its stock chart suggests. The company posted adjusted funds from operations of $2.22 per share in the third quarter and $6.85 year to date, supporting a dividend that now yields more than 8%. Occupancy sits at 90.6%, with 97% of leases carrying annual rent escalators and a weighted average lease term of 7.5 years. Liquidity remains ample at $4.2 billion, while only 7% of total debt matures through 2027.
Management is also leaning into capital discipline. Alexandria extended its $500 million share repurchase authorization through 2026, with $241.8 million still available as of October, giving it flexibility to act while shares remain depressed. Ultimately, and placed alongside heavier allocations to BDN and ONL, the ARE stake looks less like a rebound trade and more like a bet on balance sheet resilience, predictable cash flows, and a recovery in life science leasing that does not need to be fast to matter.
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 937%* — a market-crushing outperformance compared to 195% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
See the stocks »
*Stock Advisor returns as of January 23, 2026.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alexandria Real Estate Equities. The Motley Fool has a disclosure policy.